Does Akkermansia Increase GLP-1? An Honest Answer (October 2026)

01 · The core answer

Does Akkermansia increase GLP-1 in practice?

It might nudge it, but nobody can promise that it will for you. Akkermansia lives in the lining of the gut, close to the cells that release GLP-1, so researchers have naturally asked whether the two are linked. Much of the work so far is laboratory or early-stage research, and the way supplements are sold tends to run ahead of it.

If a page tells you a specific percentage rise in GLP-1 or a specific weight loss from a probiotic, treat it with caution.

Our guide to the GLP-1 Akkermansia probiotic products covers them in more detail.

02 · Your decision

Is this relevant to you, and what should you do next?

It is relevant if you are curious about gut health or want gentle lifestyle support. It is not a substitute if you need clinically meaningful weight loss. Those are different goals with different levels of evidence.

If your aim is significant, medically supervised weight loss, a licensed treatment is a different category altogether. You can review our Mounjaro pen prices and consultation or read about our wider weight loss clinic. Treatment is prescribed only after an online consultation reviewed by a GPhC-registered prescriber, and it works alongside a reduced-calorie diet and increased physical activity.

03 · How gut GLP-1 works

How your body makes GLP-1 naturally

GLP-1 is a gut hormone released after eating. It helps regulate appetite, slows how quickly the stomach empties and supports the way the body responds to insulin. Most people notice the effect as feeling fuller sooner and less hungry between meals.¹

Your own GLP-1 rises after meals and falls away quickly. That is part of why a natural boost, even if it happened, would be modest and short-lived compared with a medicine designed to act on the same receptors for a full week.

This is also why the question of what raises GLP-1 is interesting. We explore this further in our guide on increasing GLP-1 naturally.

04 · What the evidence shows

What the Akkermansia evidence does and does not show

The evidence supports curiosity, not confident claims. Akkermansia is a normal resident of many people's guts, and researchers have proposed several ways it could influence metabolism, including through the by-products bacteria make and through proteins on the bacterial surface. These are hypotheses being tested.

What the research has not established is that taking an Akkermansia supplement reliably raises your GLP-1 to a level that changes appetite or body weight in a way you would notice. Results in the lab or in animals do not automatically carry over to people, and small early human studies do not carry the weight of large randomised trials.

Be wary of three common patterns in supplement marketing:

• Mechanism language presented as if it were proof of a result.
• Dramatic weight-loss claims with no named, peer-reviewed trial behind them.
• Comparisons with prescription medicines that imply a similar effect.

None of these is a reason to avoid gut-health research. They are reasons not to expect a supplement to behave like a medicine.

05 · Supplements vs medicine

Akkermansia supplements compared with GLP-1 medicines

A licensed GLP-1 medicine acts directly on the receptor; a probiotic would at most act indirectly. Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1.¹ It is given as a once-weekly injection at a defined strength, which is very different from a capsule whose potency and live bacterial content can vary between products.

The clinical evidence for the medicine is also of a different order. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² These are trial averages and individual results vary.

Treatment is prescription-only, supplied after a consultation, and used alongside a reduced-calorie diet and increased physical activity. If you are weighing the two, the real question is how much weight you need to lose and how much clinical support you want.

06 · Who should be careful

Who should be careful with Akkermansia supplements

Anyone with a medical condition, who has a weakened immune system or who takes regular medicines should speak to a pharmacist or GP before starting a live-bacteria supplement. If you are pregnant or planning a pregnancy, speak to a pharmacist or GP first; Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive. Supplements are not assessed for individual suitability the way a prescribed medicine is, so the responsibility falls on you.

Also take care if you are already on a GLP-1 medicine. Do not add products on the assumption that they will amplify the treatment. Discuss anything new with your prescriber.

07 · Natural appetite support

Natural ways people try to support GLP-1 and appetite

No natural approach has been shown to match a licensed medicine, but some habits are sensible anyway. Regular meals built around protein and fibre-rich foods, adequate sleep and movement all support appetite regulation and general health. They are low-risk and do not require a supplement.

We have looked at several of these separately: whether fasting increases GLP-1, whether coffee does and whether a keto diet does.

Beware the phrase all-in-one GLP-1 supplement. It combines several ingredients, each with limited evidence, and dosing is not standardised across products.

08 · When treatment makes sense

When a prescription route makes more sense

If you have a significant amount of weight to lose or a weight-related health condition, a regulated medicine is worth discussing. Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first.⁴⁶ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment.

Privately, a Mounjaro pen starts at £169.99 per month for the 2.5mg starting dose (standard price, checked 11 October 2026), and a free consultation comes first. Our genuine KwikPens come through official LillyDirect supply, and ongoing monthly reviews are included. If the prescriber decides the treatment is not suitable, your order is refunded automatically in full.

Mounjaro (tirzepatide) is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber. Individual results vary, and this page is information, not a substitute for medical advice.